chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Sensory disturbance, Vitamin D decreased
Clinical narrative: Beginning day after vaccine: constant numbness/tingling sensations and hot/cold sensations throughout legs from knee to feet, with intermingled pain; same sensations of pain and numbness throughout arms and torso but less constantly. These constant sensations lasted about 2 weeks (January 20-February 1, 2022). After that time the frequency of sensations slowly decreased but intensity of pain has increased. From February 1, 2022 to present: painful pinching sensations throughout body (on arms, legs, torso, feet, joints, head) which occur randomly and without warning; approximately 2-8 sensations/hour. Occasional numbness on various parts of body.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: hospitalized with covid; fully vaccinated with booster
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Pt. Deceased  1st Dose 7/1/2021 - Moderna 08c21a 2nd Dose 7/28/2021 - Moderna 021b21a
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalization with covid; fully vaccinated with booster
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site pain, Injection site swelling
Clinical narrative: about 12 hours after shot, arm is red sore and swollen where injected
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Electromyogram, Feeling hot, Magnetic resonance imaging spinal, Muscle contractions involuntary, Sensory disturbance
Clinical narrative: facilitations in the calves, and legs. feeling of wet sensation on left toes. sensation of hot feet
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Laboratory test abnormal, Respiratory tract congestion, Throat irritation
Clinical narrative: Started feeling fatigued on 5/15 and congestion. Tested positive on 5/16. No fever but scratchy throat. Contact NP on 5/17 and started Paxlovid. Symptoms have rapidly improved since then.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Patient was given a Pfizer COVID Vaccine by mistake. He should have received a Moderna
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Confirmed Breakthrough  1st/2nd Dose - Janssen - 042a21a
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Limb mass, Pain, Trigger finger
Clinical narrative: 2 weeks after I got my 2nd shot, I got a pea sized lump on the tendon in the middle of my hand that gave me trigger finger and it was very sore. It lasted for about a month. I had to get a steroid injection into the middle of my hand and that made is gradually go away.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cardiac monitoring normal, Fatigue, SARS-CoV-2 test positive, Sinus congestion
Clinical narrative: The morning of May 13, 2022 I had a stuffy sinus cavity. Then in the early afternoon I had extreme fatigue. I thought I might have Covid. I took an at home Covid test and it was positive. I called my doctor, and they recommended that I go to the ER. I was seen in the ER, and all my vitals came back fine. They didn't do another Covid test, but they said my symptoms were similar to Covid. I was prescribed Paxlovid for 5 days. I picked it up the next morning. I finished the last course on May 18th. I'm not fully recovered yet. I still have a little fatigue. I have been isolating myself. I hope to end the isolation on May 23rd.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: X-ray normal
Clinical narrative: The morning of May 13, 2022 I had a stuffy sinus cavity. Then in the early afternoon I had extreme fatigue. I thought I might have Covid. I took an at home Covid test and it was positive. I called my doctor, and they recommended that I go to the ER. I was seen in the ER, and all my vitals came back fine. They didn't do another Covid test, but they said my symptoms were similar to Covid. I was prescribed Paxlovid for 5 days. I picked it up the next morning. I finished the last course on May 18th. I'm not fully recovered yet. I still have a little fatigue. I have been isolating myself. I hope to end the isolation on May 23rd.
Age: 90.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Acute respiratory failure, Blood creatinine increased, COVID-19, Creatinine renal clearance decreased, Pancytopenia
Clinical narrative: Admission Date: 5/12/2022 Discharge Date: 5/14/2022   HOSPITAL PROBLEMS 1. AHRF secondary to Covid-19 infection 2. CKD3b 3. Pancytopenia 4. OSA 5. CAD s/p CABG 6. COPD 7. Gout 8. Barretts esophagus  HOSPITAL COURSE: Patient is a 91 y.o. male who was admitted to hospital with AHRF secondary to Covid-19 infection.    AHRF/Covid-19 infection: Patient required 2L NC on admission to maintain saturations. Was started on 10 day course of decadron. Did not start Remdesivir due to low CrCl. Patient improved quickly, and was weaned to room air. Observed for 24hrs to ensure no further desaturations. None noted so patient discharged home to finish course of Decadron.   CKD3b: Cr mildly increased from baseline at 1.92. Remained around this level throughout admission.   Pancytopenia: Patient has know anemia secondary to CKD, as well as thrombocytopenia. WCC also noted to be decreased. Likely overall pancytopenia secondary to Covid-19 infection.
Age: 90.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: White blood cell count decreased
Clinical narrative: Admission Date: 5/12/2022 Discharge Date: 5/14/2022   HOSPITAL PROBLEMS 1. AHRF secondary to Covid-19 infection 2. CKD3b 3. Pancytopenia 4. OSA 5. CAD s/p CABG 6. COPD 7. Gout 8. Barretts esophagus  HOSPITAL COURSE: Patient is a 91 y.o. male who was admitted to hospital with AHRF secondary to Covid-19 infection.    AHRF/Covid-19 infection: Patient required 2L NC on admission to maintain saturations. Was started on 10 day course of decadron. Did not start Remdesivir due to low CrCl. Patient improved quickly, and was weaned to room air. Observed for 24hrs to ensure no further desaturations. None noted so patient discharged home to finish course of Decadron.   CKD3b: Cr mildly increased from baseline at 1.92. Remained around this level throughout admission.   Pancytopenia: Patient has know anemia secondary to CKD, as well as thrombocytopenia. WCC also noted to be decreased. Likely overall pancytopenia secondary to Covid-19 infection.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Incorrect dose administered
Clinical narrative: Patient received 0.6mL of Pfizer booster. He reported feeling "rough" the first day (5/17/22), but felt better on 5/20/22.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccines where not stored at correct temperature they had been stored in freezer instead of refrigerator
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Confirmed Outbreak  1st Dose - Moderna - 007M20A 010A21A 2nd Dose - Moderna  017F21A 3rdDose - Moderna  042J1A - 4th Dose - Moderna
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: 2nd COVID booster administered to patient who is 19 yo who is immunocompetant.  The current COVID vaccination guidelines are for 2nd boosters to be given to 50 years and over.  No adverse outcomes identified.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Mass, Pain, Tendon disorder, Trigger finger
Clinical narrative: 2 weeks after I got my 2nd shot, I got a pea sized lump on the tendon in the middle of my hand that gave me trigger finger and it was very sore. It lasted for about a month. I had to get a steroid injection into the middle of my hand and that made is gradually go away.
Age: 1.83
Sex: F
Vaccine: FLU4, HEPA
Symptoms: Erythema, Gait disturbance, Immediate post-injection reaction, Incorrect route of product administration, Pain
Clinical narrative: Patient came in for a well child check. Two vaccines were ordered influenza and hepatitis A, vaccines were verified with provider. Vaccines were administered subcutaneously instead of intramuscularly. Patient had immediate swelling and redness, developed pain and limping a few hours later. Patient followed up with primary care 5/17 (a few days later) was still limping and complaining of pain and fever. Provider recommended supportive care.
Age: 1.83
Sex: F
Vaccine: FLU4, HEPA
Symptoms: Pyrexia, Swelling
Clinical narrative: Patient came in for a well child check. Two vaccines were ordered influenza and hepatitis A, vaccines were verified with provider. Vaccines were administered subcutaneously instead of intramuscularly. Patient had immediate swelling and redness, developed pain and limping a few hours later. Patient followed up with primary care 5/17 (a few days later) was still limping and complaining of pain and fever. Provider recommended supportive care.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Confirmed Breakthrough  1st dose - 4/14/2021 Moderna 2nd dose 5/10/2021 Moderna
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Bell's palsy, Bone pain, Decreased appetite, Drooling
Clinical narrative: I am suffering from Bell's Palsy.    I have no medical history - I have only ever been in the hospital to give birth to my 3 boys.    I only go to Dr. for preventative medical care-  No medical history - Do not take any medications  Half of my face is now paralyzed.    My left eye will not close, the left side of my mouth wont work; therefore, I drool and can barely eat or drink ( I have lost 5 pounds over the past 9 days).    My left eye and left nostril are constantly watering/dripping.   My left ear throbs and is constantly ringing.   The left side of my skull is very tender - specifically my jaw up to my forehead (left side)     My vision in left eye now seems to be impaired as well.     Also, my neck is extremely tight and my left shoulder hurts.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyskinesia, Eyelid disorder, Facial paralysis, Fluid intake reduced, Lacrimation increased
Clinical narrative: I am suffering from Bell's Palsy.    I have no medical history - I have only ever been in the hospital to give birth to my 3 boys.    I only go to Dr. for preventative medical care-  No medical history - Do not take any medications  Half of my face is now paralyzed.    My left eye will not close, the left side of my mouth wont work; therefore, I drool and can barely eat or drink ( I have lost 5 pounds over the past 9 days).    My left eye and left nostril are constantly watering/dripping.   My left ear throbs and is constantly ringing.   The left side of my skull is very tender - specifically my jaw up to my forehead (left side)     My vision in left eye now seems to be impaired as well.     Also, my neck is extremely tight and my left shoulder hurts.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle tightness, Rhinorrhoea, Tinnitus, Visual impairment, Weight decreased
Clinical narrative: I am suffering from Bell's Palsy.    I have no medical history - I have only ever been in the hospital to give birth to my 3 boys.    I only go to Dr. for preventative medical care-  No medical history - Do not take any medications  Half of my face is now paralyzed.    My left eye will not close, the left side of my mouth wont work; therefore, I drool and can barely eat or drink ( I have lost 5 pounds over the past 9 days).    My left eye and left nostril are constantly watering/dripping.   My left ear throbs and is constantly ringing.   The left side of my skull is very tender - specifically my jaw up to my forehead (left side)     My vision in left eye now seems to be impaired as well.     Also, my neck is extremely tight and my left shoulder hurts.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Tendon pain
Clinical narrative: 48 hours after receiving the vaccine I started noticing soreness in the tendon in the middle of my right hand. I am concerned that the trigger finger event that happened after the 2nd dose and the 3rd dose is happening again.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was  refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphoedema
Clinical narrative: Symptoms started the and was going on the whole time but I was busy and might not have noticed, and it was not as pronounced. I started to get symptoms of lymphedema complicated by other things going on (things listed in chronic/longstanding health conditions). Symptoms worsened after 2nd booster, please see new report.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test positive
Clinical narrative: positive covid test in vaccinated and boostered asymptomatic pt
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Moderna booster COVID 19 Vaccine (0.25ml) was administered to patient one month early. Patient received the first Booster dose on 2/17/22. Second Booster dose  was administered on 5/20/2022.  Patient was oriented and alert after vaccine administration. Patient denied any side effects or any adverse reaction. Patient was monitored for an additional 15 minutes
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Malaise, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: *****************COVID BREAKTHROUGH CASE***************************** I was on a cruise ship which is where I  contracted COVID. I began felling sick May 7, I thought it was allergies to pollen. Some of the other people on the ship had COVID so I tested myself I was positive (PCR) Monday the 9th. Called into my doctor and told me to treat the symptoms. Main Symptoms: Fatigue; Minor Congestion. The worst congestion was the 16th.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: *****************COVID BREAKTHROUGH CASE***************************** I was on a cruise ship which is where I  contracted COVID. I began felling sick May 7, I thought it was allergies to pollen. Some of the other people on the ship had COVID so I tested myself I was positive (PCR) Monday the 9th. Called into my doctor and told me to treat the symptoms. Main Symptoms: Fatigue; Minor Congestion. The worst congestion was the 16th.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchitis, Feeling abnormal, Headache, Hypersomnia, Impaired work ability
Clinical narrative: I received my 2nd  booster shot on 03/02/2021 on the same day I  wasn't feeling good.  on  Thursday i went home and slept, i felt achy all over my body.  I slept all weekend , i  didn't eat like eating. On Monday i had a low grade fever. i had symptoms like COVID.  I didn't had any breathing issue.  I did a tele health she told me to take days off work.  i took Tylenol and Mucinex. i had headache.  I  had severe bronchitis, and breathing treatments later on. i was better after 1 week.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pain, Pyrexia
Clinical narrative: I received my 2nd  booster shot on 03/02/2021 on the same day I  wasn't feeling good.  on  Thursday i went home and slept, i felt achy all over my body.  I slept all weekend , i  didn't eat like eating. On Monday i had a low grade fever. i had symptoms like COVID.  I didn't had any breathing issue.  I did a tele health she told me to take days off work.  i took Tylenol and Mucinex. i had headache.  I  had severe bronchitis, and breathing treatments later on. i was better after 1 week.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Acute respiratory failure, Angiogram pulmonary normal, COVID-19, COVID-19 pneumonia
Clinical narrative: COVID Vaccine Breakthrough Case   Moderna Dose 1 2/6/21 (032L20A) Moderna Dose 2 3/6/21 (024M20A) COVID Positive 12/11/2021  12/15/21: Patient is an 82yo male with medical history of DMT2, cardiac dysrhythmia , CKD, COPD on 3 L home oxygen, HLD, BPH, s/p Nephrectomy,. Patient is being admitted for worsening COVID symptoms and worsening respiratory failure. Patient tested positive for COVID Dec 11 . He was at the infusion center today when he acutely decompensated 5mins into his infusion with two syncopal episodes. On arrival to ER he was initially saturating 89% on 5L but progressed to require vapotherm at 20L 65%. CT angio chest and CT abdomen ordered for abdominal pain is likely to be suboptimal because patient's IV line infiltrated and not enough contrast was administered. CT head ordered because of patient endorsing a fall was negative. Pulmonology was consulted by ER provider.  12/20/21: Patient is a 86-year-old male history of chronic COPD home oxygen dependent 3 L at baseline admitted to the hospital for acute on chronic hypoxic respiratory failure due to COVID-19 pneumonia, patient was treated with supplemental oxygen, remdesivir and Decadron, as time progressed patient clinically improved, oxygen was wean down to home oxygen.  Patient was evaluated by therapy recommended skilled nursing facility, however patient declined but he was agreeable with Agency.  Patient will be discharged home with Agency, recommended follow-up with PCP within 1 week.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram abdomen normal, Computerised tomogram head normal, Fall, Malaise, Oxygen saturation decreased
Clinical narrative: COVID Vaccine Breakthrough Case   Moderna Dose 1 2/6/21 (032L20A) Moderna Dose 2 3/6/21 (024M20A) COVID Positive 12/11/2021  12/15/21: Patient is an 82yo male with medical history of DMT2, cardiac dysrhythmia , CKD, COPD on 3 L home oxygen, HLD, BPH, s/p Nephrectomy,. Patient is being admitted for worsening COVID symptoms and worsening respiratory failure. Patient tested positive for COVID Dec 11 . He was at the infusion center today when he acutely decompensated 5mins into his infusion with two syncopal episodes. On arrival to ER he was initially saturating 89% on 5L but progressed to require vapotherm at 20L 65%. CT angio chest and CT abdomen ordered for abdominal pain is likely to be suboptimal because patient's IV line infiltrated and not enough contrast was administered. CT head ordered because of patient endorsing a fall was negative. Pulmonology was consulted by ER provider.  12/20/21: Patient is a 86-year-old male history of chronic COPD home oxygen dependent 3 L at baseline admitted to the hospital for acute on chronic hypoxic respiratory failure due to COVID-19 pneumonia, patient was treated with supplemental oxygen, remdesivir and Decadron, as time progressed patient clinically improved, oxygen was wean down to home oxygen.  Patient was evaluated by therapy recommended skilled nursing facility, however patient declined but he was agreeable with Agency.  Patient will be discharged home with Agency, recommended follow-up with PCP within 1 week.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory failure, SARS-CoV-2 test positive, Syncope, Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Case   Moderna Dose 1 2/6/21 (032L20A) Moderna Dose 2 3/6/21 (024M20A) COVID Positive 12/11/2021  12/15/21: Patient is an 82yo male with medical history of DMT2, cardiac dysrhythmia , CKD, COPD on 3 L home oxygen, HLD, BPH, s/p Nephrectomy,. Patient is being admitted for worsening COVID symptoms and worsening respiratory failure. Patient tested positive for COVID Dec 11 . He was at the infusion center today when he acutely decompensated 5mins into his infusion with two syncopal episodes. On arrival to ER he was initially saturating 89% on 5L but progressed to require vapotherm at 20L 65%. CT angio chest and CT abdomen ordered for abdominal pain is likely to be suboptimal because patient's IV line infiltrated and not enough contrast was administered. CT head ordered because of patient endorsing a fall was negative. Pulmonology was consulted by ER provider.  12/20/21: Patient is a 86-year-old male history of chronic COPD home oxygen dependent 3 L at baseline admitted to the hospital for acute on chronic hypoxic respiratory failure due to COVID-19 pneumonia, patient was treated with supplemental oxygen, remdesivir and Decadron, as time progressed patient clinically improved, oxygen was wean down to home oxygen.  Patient was evaluated by therapy recommended skilled nursing facility, however patient declined but he was agreeable with Agency.  Patient will be discharged home with Agency, recommended follow-up with PCP within 1 week.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: none
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Fluid retention, Joint range of motion decreased, Lymphoedema, Musculoskeletal stiffness
Clinical narrative: 30 minutes after booster symptoms started/worsened. I got treatment for lymphedema and I was going once a week and it wouldn't go away. After a month we got it under control somewhat and it was twice as big as the other side, at least 10% larger. 30 minutes after booster it was burning, swollen, and my under arm was swollen again. The co-factors were resolved and so I felt it this time. I talked to my doctor and she said I'm not the only cancer survivor that this has happened to and she's getting a lot of information from patients with cancer from years ago that have lymphoedema after being vaccinated. Someone needs to call the HCP. Please call me for release of medical records to attach. I went once a week for 4 weeks to see if it would go away and that required me to go 3 times a week for 3 weeks and the 4th week I got it wrapped up and it was all tied and stiff with limited range of motion. At that point, they would try and squeeze that fluid back and they also ordered me a pump and I have to do that every day and it's a prompt exercise and the pump just came yesterday and I'm off that mummy wrap and have more range of motion. It is sore and achy and I have a compression of my arm and hand so that's the treatment and there's not much else they can do for it except a surgery and that's only 30% effective.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Oedema peripheral, Pain in extremity, Pneumatic compression therapy, Swelling
Clinical narrative: 30 minutes after booster symptoms started/worsened. I got treatment for lymphedema and I was going once a week and it wouldn't go away. After a month we got it under control somewhat and it was twice as big as the other side, at least 10% larger. 30 minutes after booster it was burning, swollen, and my under arm was swollen again. The co-factors were resolved and so I felt it this time. I talked to my doctor and she said I'm not the only cancer survivor that this has happened to and she's getting a lot of information from patients with cancer from years ago that have lymphoedema after being vaccinated. Someone needs to call the HCP. Please call me for release of medical records to attach. I went once a week for 4 weeks to see if it would go away and that required me to go 3 times a week for 3 weeks and the 4th week I got it wrapped up and it was all tied and stiff with limited range of motion. At that point, they would try and squeeze that fluid back and they also ordered me a pump and I have to do that every day and it's a prompt exercise and the pump just came yesterday and I'm off that mummy wrap and have more range of motion. It is sore and achy and I have a compression of my arm and hand so that's the treatment and there's not much else they can do for it except a surgery and that's only 30% effective.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Bladder catheterisation, Blood creatinine increased, Blood potassium decreased, COVID-19
Clinical narrative: COVID Vaccine Breakthrough Case  Moderna Dose 1 2/29/21 (023M20A) COVID Positive 12/14/21  12/18/21: The patient is a 74 year old male with a past medical history of congestive heart failure LVEF 50-55%, COPD, type 2 diabetes mellitus, Parkinson's disease and tobacco use. The patient presented to ED with complaints of generalized weakness for the past 1 week.  The patient was diagnosed with COVID on 12/14.  He has complaints of a mild cough, fever, nausea without vomiting, decreased appetite and oral intake.  He denies any chest pain.  He denies any shortness of breath.  He received 1 COVID-19 vaccine back in February.  He lives at home at baseline with his wife and daughter.  He is ambulatory feel walker.  Patient has become progressively weaker since being diagnosed with COVID and has been unable to ambulate and care for himself. Per chart review his wife and daughter are not able to care for him at this time.  He does have a indwelling Foley catheter at that this time but he is unaware why.  On arrival to ED patient's vital signs were stable. Laboratory findings were significant for hypokalemia 3.0. CKD stage G 3A creatinine 1.31.  ProBNP 4221. D-dimer 1.52.  CT chest no PE.  Mild ground-glass airspace disease in the right lung suggesting mild pneumonitis.  Possible mucus plugging in the left lower lobe segmental bronchus. Emphysema.  Levaquin initiated in ED.  Decadron given. Zofran given.  Potassium 40 mEq 2 tabs p.o. given.  IV fluid resuscitation was given with NS 0.9% 1.5 L bolus.  12/21/21: As noted patient presented with complaints of generalized weakness for week prior to arrival was diagnosed with the COVID-19 on 12/14.  Only received 1 dose of vaccine in February.  Was found to pneumonia on imaging, likely viral in nature, vitamin C and zinc vitamin-D nebulizer treatments and IV fluids.  Patient however did not require any supplemental oxygen.  Did not qualify for remdesivir, steroids.  Gradually improved p.o. intake improved working with therapy was able to ambulate.  P.o. intake improved,  IV fluids were discontinued.  Therapy recommended home with home health supportive cares.  All ED in RTC precautions were provided to patient, endorses understanding and in agreement with plan as outlined.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic kidney disease, Computerised tomogram thorax abnormal, Cough, Decreased appetite, Emphysema
Clinical narrative: COVID Vaccine Breakthrough Case  Moderna Dose 1 2/29/21 (023M20A) COVID Positive 12/14/21  12/18/21: The patient is a 74 year old male with a past medical history of congestive heart failure LVEF 50-55%, COPD, type 2 diabetes mellitus, Parkinson's disease and tobacco use. The patient presented to ED with complaints of generalized weakness for the past 1 week.  The patient was diagnosed with COVID on 12/14.  He has complaints of a mild cough, fever, nausea without vomiting, decreased appetite and oral intake.  He denies any chest pain.  He denies any shortness of breath.  He received 1 COVID-19 vaccine back in February.  He lives at home at baseline with his wife and daughter.  He is ambulatory feel walker.  Patient has become progressively weaker since being diagnosed with COVID and has been unable to ambulate and care for himself. Per chart review his wife and daughter are not able to care for him at this time.  He does have a indwelling Foley catheter at that this time but he is unaware why.  On arrival to ED patient's vital signs were stable. Laboratory findings were significant for hypokalemia 3.0. CKD stage G 3A creatinine 1.31.  ProBNP 4221. D-dimer 1.52.  CT chest no PE.  Mild ground-glass airspace disease in the right lung suggesting mild pneumonitis.  Possible mucus plugging in the left lower lobe segmental bronchus. Emphysema.  Levaquin initiated in ED.  Decadron given. Zofran given.  Potassium 40 mEq 2 tabs p.o. given.  IV fluid resuscitation was given with NS 0.9% 1.5 L bolus.  12/21/21: As noted patient presented with complaints of generalized weakness for week prior to arrival was diagnosed with the COVID-19 on 12/14.  Only received 1 dose of vaccine in February.  Was found to pneumonia on imaging, likely viral in nature, vitamin C and zinc vitamin-D nebulizer treatments and IV fluids.  Patient however did not require any supplemental oxygen.  Did not qualify for remdesivir, steroids.  Gradually improved p.o. intake improved working with therapy was able to ambulate.  P.o. intake improved,  IV fluids were discontinued.  Therapy recommended home with home health supportive cares.  All ED in RTC precautions were provided to patient, endorses understanding and in agreement with plan as outlined.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Gait inability, Hypokalaemia, Hypophagia, Laboratory test
Clinical narrative: COVID Vaccine Breakthrough Case  Moderna Dose 1 2/29/21 (023M20A) COVID Positive 12/14/21  12/18/21: The patient is a 74 year old male with a past medical history of congestive heart failure LVEF 50-55%, COPD, type 2 diabetes mellitus, Parkinson's disease and tobacco use. The patient presented to ED with complaints of generalized weakness for the past 1 week.  The patient was diagnosed with COVID on 12/14.  He has complaints of a mild cough, fever, nausea without vomiting, decreased appetite and oral intake.  He denies any chest pain.  He denies any shortness of breath.  He received 1 COVID-19 vaccine back in February.  He lives at home at baseline with his wife and daughter.  He is ambulatory feel walker.  Patient has become progressively weaker since being diagnosed with COVID and has been unable to ambulate and care for himself. Per chart review his wife and daughter are not able to care for him at this time.  He does have a indwelling Foley catheter at that this time but he is unaware why.  On arrival to ED patient's vital signs were stable. Laboratory findings were significant for hypokalemia 3.0. CKD stage G 3A creatinine 1.31.  ProBNP 4221. D-dimer 1.52.  CT chest no PE.  Mild ground-glass airspace disease in the right lung suggesting mild pneumonitis.  Possible mucus plugging in the left lower lobe segmental bronchus. Emphysema.  Levaquin initiated in ED.  Decadron given. Zofran given.  Potassium 40 mEq 2 tabs p.o. given.  IV fluid resuscitation was given with NS 0.9% 1.5 L bolus.  12/21/21: As noted patient presented with complaints of generalized weakness for week prior to arrival was diagnosed with the COVID-19 on 12/14.  Only received 1 dose of vaccine in February.  Was found to pneumonia on imaging, likely viral in nature, vitamin C and zinc vitamin-D nebulizer treatments and IV fluids.  Patient however did not require any supplemental oxygen.  Did not qualify for remdesivir, steroids.  Gradually improved p.o. intake improved working with therapy was able to ambulate.  P.o. intake improved,  IV fluids were discontinued.  Therapy recommended home with home health supportive cares.  All ED in RTC precautions were provided to patient, endorses understanding and in agreement with plan as outlined.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Lung opacity, Nausea, Pneumonia, Pneumonitis, Prohormone brain natriuretic peptide increased
Clinical narrative: COVID Vaccine Breakthrough Case  Moderna Dose 1 2/29/21 (023M20A) COVID Positive 12/14/21  12/18/21: The patient is a 74 year old male with a past medical history of congestive heart failure LVEF 50-55%, COPD, type 2 diabetes mellitus, Parkinson's disease and tobacco use. The patient presented to ED with complaints of generalized weakness for the past 1 week.  The patient was diagnosed with COVID on 12/14.  He has complaints of a mild cough, fever, nausea without vomiting, decreased appetite and oral intake.  He denies any chest pain.  He denies any shortness of breath.  He received 1 COVID-19 vaccine back in February.  He lives at home at baseline with his wife and daughter.  He is ambulatory feel walker.  Patient has become progressively weaker since being diagnosed with COVID and has been unable to ambulate and care for himself. Per chart review his wife and daughter are not able to care for him at this time.  He does have a indwelling Foley catheter at that this time but he is unaware why.  On arrival to ED patient's vital signs were stable. Laboratory findings were significant for hypokalemia 3.0. CKD stage G 3A creatinine 1.31.  ProBNP 4221. D-dimer 1.52.  CT chest no PE.  Mild ground-glass airspace disease in the right lung suggesting mild pneumonitis.  Possible mucus plugging in the left lower lobe segmental bronchus. Emphysema.  Levaquin initiated in ED.  Decadron given. Zofran given.  Potassium 40 mEq 2 tabs p.o. given.  IV fluid resuscitation was given with NS 0.9% 1.5 L bolus.  12/21/21: As noted patient presented with complaints of generalized weakness for week prior to arrival was diagnosed with the COVID-19 on 12/14.  Only received 1 dose of vaccine in February.  Was found to pneumonia on imaging, likely viral in nature, vitamin C and zinc vitamin-D nebulizer treatments and IV fluids.  Patient however did not require any supplemental oxygen.  Did not qualify for remdesivir, steroids.  Gradually improved p.o. intake improved working with therapy was able to ambulate.  P.o. intake improved,  IV fluids were discontinued.  Therapy recommended home with home health supportive cares.  All ED in RTC precautions were provided to patient, endorses understanding and in agreement with plan as outlined.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Case  Moderna Dose 1 2/29/21 (023M20A) COVID Positive 12/14/21  12/18/21: The patient is a 74 year old male with a past medical history of congestive heart failure LVEF 50-55%, COPD, type 2 diabetes mellitus, Parkinson's disease and tobacco use. The patient presented to ED with complaints of generalized weakness for the past 1 week.  The patient was diagnosed with COVID on 12/14.  He has complaints of a mild cough, fever, nausea without vomiting, decreased appetite and oral intake.  He denies any chest pain.  He denies any shortness of breath.  He received 1 COVID-19 vaccine back in February.  He lives at home at baseline with his wife and daughter.  He is ambulatory feel walker.  Patient has become progressively weaker since being diagnosed with COVID and has been unable to ambulate and care for himself. Per chart review his wife and daughter are not able to care for him at this time.  He does have a indwelling Foley catheter at that this time but he is unaware why.  On arrival to ED patient's vital signs were stable. Laboratory findings were significant for hypokalemia 3.0. CKD stage G 3A creatinine 1.31.  ProBNP 4221. D-dimer 1.52.  CT chest no PE.  Mild ground-glass airspace disease in the right lung suggesting mild pneumonitis.  Possible mucus plugging in the left lower lobe segmental bronchus. Emphysema.  Levaquin initiated in ED.  Decadron given. Zofran given.  Potassium 40 mEq 2 tabs p.o. given.  IV fluid resuscitation was given with NS 0.9% 1.5 L bolus.  12/21/21: As noted patient presented with complaints of generalized weakness for week prior to arrival was diagnosed with the COVID-19 on 12/14.  Only received 1 dose of vaccine in February.  Was found to pneumonia on imaging, likely viral in nature, vitamin C and zinc vitamin-D nebulizer treatments and IV fluids.  Patient however did not require any supplemental oxygen.  Did not qualify for remdesivir, steroids.  Gradually improved p.o. intake improved working with therapy was able to ambulate.  P.o. intake improved,  IV fluids were discontinued.  Therapy recommended home with home health supportive cares.  All ED in RTC precautions were provided to patient, endorses understanding and in agreement with plan as outlined.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Asthenia, Blood glucose normal, COVID-19, COVID-19 pneumonia
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/22/21 (ER8731) Pfizer Dose 2 5/14/21 (EW0168) COVID Positive 12/12/21  12/19/21: Patient is a 61-year-old male with a past medical history significant for COPD, hypertension, hepatitis-C, type 2 diabetes, BPH, OSA, obesity, tobacco user. The patient presents to the ED today with complaints of worsening shortness of breath. The patient states he tested positive for COVID-19 on 12/12/2021 and his symptoms began on 12/10/2021. The patient's accompanying symptoms include fatigue, generalized weakness, body aches, and cough. The patient denies fever, chills, sputum production, chest pain, nausea, vomiting or diarrhea.  The patient states he has used 15 albuterol nebulizer treatments since midnight last night due to shortness of breath. He states his shortness of breath worsens with exertion and he experiences dizziness and lightheadedness with ambulation. The patient is not vaccinated against COVID-19. He is an every day smoker, states he smokes about 0.5-1 packs per day. He denies any alcohol use or illicit drug abuse.   Upon arrival to ED patient's temperature is 99.2°, heart rate 108, respirations 22, pulse ox 92% on room air, blood pressure 132/94.  Patient was placed on 3 L oxygen via nasal cannula to maintain O2 saturations greater than 90% as patient had episode of desaturation with ambulation.  CT angio reveals no pulmonary embolism, patchy airspace disease in bilateral lungs likely represent viral pneumonia.  Patient's laboratory findings are significant for glucose 101, proBNP 197, d-dimer 0.70.  500 mg IV azithromycin, 1 g IV Rocephin, 125 mg IV Solu-Medrol, and DuoNeb x1 in the ED.  12/23/21: -Patient is a 61 yo male who is unvaccinated against COVID  who was being managed for COVID pneumonia with hypoxia  -He was managed with Ceftriaxone , Azithromycin , Decadron and remdesivir  -His symptoms improved  -Home oxygen test done showed he requires 3L oxygen on exertion and none at rest  -He will be discharged with 1 day course of levaquin, 7 days of decadron and covid supportive treatments  -Patient will be discharged.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dizziness, Dyspnoea, Dyspnoea exertional, Fatigue
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/22/21 (ER8731) Pfizer Dose 2 5/14/21 (EW0168) COVID Positive 12/12/21  12/19/21: Patient is a 61-year-old male with a past medical history significant for COPD, hypertension, hepatitis-C, type 2 diabetes, BPH, OSA, obesity, tobacco user. The patient presents to the ED today with complaints of worsening shortness of breath. The patient states he tested positive for COVID-19 on 12/12/2021 and his symptoms began on 12/10/2021. The patient's accompanying symptoms include fatigue, generalized weakness, body aches, and cough. The patient denies fever, chills, sputum production, chest pain, nausea, vomiting or diarrhea.  The patient states he has used 15 albuterol nebulizer treatments since midnight last night due to shortness of breath. He states his shortness of breath worsens with exertion and he experiences dizziness and lightheadedness with ambulation. The patient is not vaccinated against COVID-19. He is an every day smoker, states he smokes about 0.5-1 packs per day. He denies any alcohol use or illicit drug abuse.   Upon arrival to ED patient's temperature is 99.2°, heart rate 108, respirations 22, pulse ox 92% on room air, blood pressure 132/94.  Patient was placed on 3 L oxygen via nasal cannula to maintain O2 saturations greater than 90% as patient had episode of desaturation with ambulation.  CT angio reveals no pulmonary embolism, patchy airspace disease in bilateral lungs likely represent viral pneumonia.  Patient's laboratory findings are significant for glucose 101, proBNP 197, d-dimer 0.70.  500 mg IV azithromycin, 1 g IV Rocephin, 125 mg IV Solu-Medrol, and DuoNeb x1 in the ED.  12/23/21: -Patient is a 61 yo male who is unvaccinated against COVID  who was being managed for COVID pneumonia with hypoxia  -He was managed with Ceftriaxone , Azithromycin , Decadron and remdesivir  -His symptoms improved  -Home oxygen test done showed he requires 3L oxygen on exertion and none at rest  -He will be discharged with 1 day course of levaquin, 7 days of decadron and covid supportive treatments  -Patient will be discharged.